CSI Pharmacy Secures California Non-Resident Permit, Achieving Nationwide Reach
Bringing Personalized Specialty Pharmacy Services to All 50 States
NASHVILLE, Tenn., June 4, 2025 /PRNewswire/ -- CSI Pharmacy is proud to reveal that, as of May 13, 2025, it is officially licensed to serve patients in all 50 states with the approval of two non-resident California pharmacy permits. This milestone marks a major achievement in CSI Pharmacy's mission to deliver personalized, patient-centered specialty pharmacy care to individuals living with chronic and rare diseases.
James Sheets, PharmD, CEO and Founder of CSI Pharmacy, shared his thoughts on the significance of this expansion:
"Reaching all 50 states is more than a milestone for us — it's a reflection of our commitment to ensure patients receive the highest level of care and comfort. California is home to one of the most diverse patient populations in the country, and we're excited to deliver our compassionate, personalized care to communities that need it most. At CSI, we believe in 'individualized therapies designed to be as unique as you,' and we're proud to extend that promise to every corner of the nation."
With licensure secured, CSI Pharmacy can begin serving California-based patients immediately. Several patient transfers are already in progress, and their team is prepared to onboard additional referrals.
To meet growing demand, CSI Pharmacy will expand its team to support this new territory in the coming months. Additionally, CSI Pharmacy is exploring physical space options in the state as well. While this physical location is not required to serve patients, the future brick and mortar expansion represents the passion they hold to serve patients well and quickly.
The new licenses not only emphasize CSI Pharmacy's nationwide capabilities, but it also highlights an ongoing commitment to access, equity, and personalized care across every community CSI Pharmacy serves.
About CSI PharmacyCSI Pharmacy is a nationwide specialty infusion pharmacy focused on supporting patients with chronic and rare conditions through home-based immunoglobulin (IVIg and SCIg) therapies and other complex medications. The expert team works closely with providers, insurance groups, and advocacy organizations to ensure timely access to life-changing treatments with compassion, precision, and purpose.
For more information, visit www.csipharmacy.com or contact info@csipharmacy.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/csi-pharmacy-secures-california-non-resident-permit-achieving-nationwide-reach-302473723.html
SOURCE CSI Pharmacy
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
10 minutes ago
- Associated Press
Matter Neuroscience announces collaboration with Stanford Medicine combining Matter protocol with real-time fMRI neurofeedback to support emotion-based interventions in depression
This collaboration sets out to explore whether using the Matter Neuroscience protocol combined with real-time neurofeedback can influence emotional brain networks relevant to depression. PALO ALTO, Calif., June 3, 2025 /PRNewswire/ -- Matter Neuroscience is pleased to announce a collaboration with Stanford Medicine's Psychiatry and Behavioral Sciences Department. The controlled, multi-arm study will enroll at least 210 depressed patients with the objective to significantly reduce clinical endpoints using real-time 7T fMRI neurofeedback in combination with the Matter protocol selectively activating key brain areas hosting distinct positive emotions. The clinical endpoints are paralleled with several molecular, emotional and behavioral biomarkers. If successful, the findings can be integrated into a full-scale clinical trial with the potential to inform future non-pharmaceutical curative therapies for depression. Professor Nolan Williams, M.D. an Associate Professor of Psychiatry and Behavioral Sciences at Stanford University and Director of the Stanford Brain Stimulation Lab will serve as the Principal Investigator on the study. 'This study allows us to investigate how targeted emotion training, guided by real-time fMRI, may influence mood-related brain circuits,' said Dr. Williams. 'What makes this particularly interesting is the opportunity to evaluate both the neural mechanisms involved in emotion regulation and the feasibility of translating this approach into a deliverable treatment in the clinic or home one day.' Matter CEO Axel Bouchon shares, 'After we have seen positive effects in emotional wellbeing of healthy individuals in our studies in the past 4-5 years, it is just one of the most exciting studies I have witnessed in my career. Ultimately, we try to use the latest advancements in MRI technology and the patients' good memories as a personalized medicine to reduce, maybe permanently cure, their depressive symptoms.' About Matter Matter Neuroscience was founded in 2019 by Axel Bouchon and Ben Goldhirsh. Matter's mission is to use neuroscience to help people live longer, healthier, happier lives. Matter Neuroscience runs a consumer technology business ( ) and a medical business addressing healthy individuals and patients, respectively. Matter is led by CEO Axel Bouchon (Moderna, Bayer, ARCH Venture Partners.) Ben Goldhirsh (GOOD Worldwide and the Goldhirsh Foundation) serves as Matter's Chairman and Head of Product. Visit to learn more about Matter. Download the Matter app, named 'App of the Day' on Apple's App Store. Follow Matter on Instagram and Tiktok for education and inspiration for living a happier life. About the Matter Protocol Matter Neuroscience and its academic partners in Maastricht and Copenhagen have conducted several research studies successfully identifying a human map for distinct positive emotions in the brain. Using this map as a directional biomarker, a team led by Professor Rainer Goebel at the Maastricht Brain Imaging Center in the Netherlands developed a protocol that allows for training and intensifying distinct human emotions using real-time fMRI neurofeedback with autobiographical memories. View original content to download multimedia: SOURCE Matter Neuroscience
Yahoo
23 minutes ago
- Yahoo
Takeover of GP surgery 'concerning'
Campaigners are holding a tug-of-war to highlight what they say is the threat to a community-run, non-profit GP surgery in Brighton from a private company. The Whitehawk surgery is currently run by the Wellsbourne Healthcare Community Interest Company, but it could be handed over to Leeds-based One Medical Group after NHS Sussex started procuring for a new contract. NHS Sussex said it could not comment on the procurement process as it was still under way. Janet Sang, part of Sussex Defend NHS, said the campaign group was "extremely concerned" that an "effective and well-loved GP service" could be transferred to a profit-making entity. "We believe this is... not in the best interests of the people of Whitehawk," she added. One Medical Group, which said it had more than two decades of experience in "delivering high-quality primary care services across the UK", said it could not comment as the procurement process was ongoing. It added it had "consistently delivered [NHS services] to the highest standard across diverse demographics". "We pride ourselves on.... our collaborative approach with local communities, ensuring that healthcare is both reflective and responsive to local needs," it continued. NHS Sussex said it needed to procure a new contract for running the doctor's surgery, which serves around 8,300 people, as the current one has expired. It said the new contract had been designed to meet the needs of the local population in what it called one of the most deprived areas in Sussex. Wellsbourne Healthcare CIC took over the GP surgery several years ago after the previous private provider walked away, according to the Local Democracy Reporting Service. Anger over uncertain future of GP surgery Brighton & Hove City Councillor David McGregor, who said he planned to attend the tug-of-war event, said the Wellsbourne Healthcare CIC had done a "fantastic job" and NHS Sussex should "reconsider". Chris Ward, Labour MP for Brighton Kemptown and Peacehaven, has started a petition - titled Save Wellsbourne Healthcare - that has more than 3,000 signatures as of 5 June. Sarah Webb, business manager at Wellsbourne Healthcare CIC, previously urged NHS Sussex to talk to the people of Whitehawk. "Listen to residents," she told BBC Radio Sussex in May. Follow BBC Sussex on Facebook, X and Instagram. Send your story ideas to southeasttoday@ or WhatsApp us on 08081 002250. Anger over uncertain future of GP surgery NHS Sussex Local Democracy Reporting Service
TechCrunch
27 minutes ago
- TechCrunch
Court denies Apple's request to pause ruling on App Store payment fees
A U.S. court denied Apple a stay on a ruling that requires the company to stop charging developers for payments made outside the App Store through links in apps. This means in the U.S., Apple will no longer be able to charge developers a fee when customers click on a link within their app that takes them outside the App Store for payment, resulting in a potential loss of revenue to the company. 'Apple 'bears the burden of showing that the circumstances justify an exercise of [our] discretion,'' the court said in a filing. 'After reviewing the relevant factors, we are not persuaded that a stay is appropriate,' it added. Epic Games' head Tim Sweeney applauded the court's ruling and said, 'The long national nightmare of Apple tax is ended,' in a post on X. Apple's stay is denied by the 9th Circuit Court. The long national nightmare of the Apple tax is ended. May next week's WWDC be the Apple-led celebration of freedom that developers and users have long deserved. — Tim Sweeney (@TimSweeneyEpic) June 4, 2025 In April, Judge Yvonne Gonzalez Rogers ruled in favor of Epic Games, saying that Apple was in 'willful violation' of a 2021 injunction that barred the company from forcing anticompetitive pricing. This essentially means that Apple must change the App Store rules and allow developers to freely link to their website for purchasing digital goods. In response, Apple filed an emergency motion last month seeking a stay on the court's ruling. The company also filed an appeal against the ruling around the same time. Last year, Apple began allowing other apps to link out and use non-Apple payment mechanisms, but it still took a 27% fee and added what critics called 'scare screens.' With the new ruling, both practices will be eliminated. Large companies are already making changes to their apps, with Spotify and Amazon publishing new updates that let users pay for their subscriptions and purchases outside the App Store. Techcrunch event Save $200+ on your TechCrunch All Stage pass Build smarter. Scale faster. Connect deeper. Join visionaries from Precursor Ventures, NEA, Index Ventures, Underscore VC, and beyond for a day packed with strategies, workshops, and meaningful connections. Save $200+ on your TechCrunch All Stage pass Build smarter. Scale faster. Connect deeper. Join visionaries from Precursor Ventures, NEA, Index Ventures, Underscore VC, and beyond for a day packed with strategies, workshops, and meaningful connections. Boston, MA | REGISTER NOW With the Worldwide Developer Conference (WWDC) slotted for next week, this is a big blow to Apple. Earlier this week, the company published a report saying that it generated $1.3 trillion in billings and sales in 2024. It added 90% of those sales didn't generate commission revenue for Apple.
